Studies on tumor induced angiogenesis.
Methods were developed to test the angiogenic response to human tumor implants and various biologic agents in the cornea of rabbits and non-human primates (Macaca arctoides). Human malignant melanoma tissue and crude platelet derived growth factor (PDGF) preparations had significant angiogenic effects. Purified, recombinant PDGF preparations were also effective initiators. Hemorheologic agents which also inhibit platelet aggregation [e.g. pentoxifylline (Px) (Trental) (also found to release PgI2 and tissue plasminogen activator (t-PA)] inhibited human tumor implant-induced angiogenesis. Sodium diethyldithiocarbamate (DDTC), a metal complexing agent with special affinity to copper and anti-thyroid as well as immune stimulating activity, was shown to be anti-angiogenic and to increase the effect of Px. The anti-fibrinolytic agents epsilon amino caproic acid (EACA) and tranexamic acid (t-AMCHA) were anti-angiogenic.
Ambrus
J L
JL
Roswell Park Cancer Institute, Buffalo, NY 14263.
Ambrus
C M
CM
Toumbis
C A
CA
Forgach
P
P
Karakousis
C P
CP
Niswander
P
P
Lane
W
W
D000818:Animals; D003315:Cornea / Q000098:blood supply; D004050:Ditiocarb / Q000494:pharmacology; D006801:Humans; D008251:Macaca; D009369:Neoplasms / Q000503:physiopathology*; D009389:Neovascularization, Pathologic; D010431:Pentoxifylline / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011817:Rabbits
D010982:Platelet-Derived Growth Factor; D004050:Ditiocarb; D010431:Pentoxifylline